TecAustron Partnership
Bringing Global Particle Therapy Expertise to India
Weembrace is bringing next-generation particle therapy to India.
Weembrace has been appointed the exclusive importer, commercialisation and distribution partner for TecAustron, a MedAustron Group company, in India.
Through this collaboration, Weembrace will introduce TecAustron's advanced particle therapy technologies to healthcare providers and research institutions — strengthening access to next-generation oncology solutions across India.
Why TecAustron?
TecAustron combines research excellence, advanced accelerator engineering and clinical expertise to develop next-generation particle therapy solutions. As part of the MedAustron ecosystem, it brings together scientific innovation and real-world treatment experience to support the future of precision oncology.
Research Driven Innovation
2168 Patients Registered
7 Active Clinical Studies
Creating More Evidence
Synchrotron Based Accelerator
Variable Beam Energy Extraction
Degrader Free Delivery
Minimum Neutron Load
Multi-ion Capability
Flexible & Scalable Architecture
Integrated Clinical Workflow
TecAustron- not just any particle therapy provider
systems
- • R&D Support
- • Technology Improvement
- • Non-clinical Research Support
- • Clinical Support and Training
- • Clinincal Research Support
- • Patient Support
Synchrotron Based Systems
Designed in accordance with highest quality standards (IEC/ISO)
MULTI-ION 800
Contribute not only to cancer treatment, but also help shaping its future
IONS HELIUM
IONS
COMPACT 200+
Establish an additional radiotherapy method quickly and cost-effectively
Designed for Smarter Investment.
Built for Future Growth.
Rethinking Particle Therapy Infrastructure
As providers evaluate advanced radiation-oncology technologies, there is a growing need for solutions that are clinically advanced yet practical to implement, scalable to expand and sustainable to operate.
TecAustron enables:
- Flexible infrastructure planning
- Modular expansion aligned with future demand
- Optimised facility footprint
- Research-backed accelerator technology
- Long-term operational efficiency
Adoption in India
Enabling Successful Adoption in India
Weembrace supports healthcare institutions across the entire adoption journey — from market entry and commercialisation to project execution, technical coordination and long-term partnership.
Commercialisation & Market Development
Introducing TecAustron's particle therapy portfolio to Indian healthcare providers and research institutions.
Project Coordination & Implementation Support
End-to-end coordination from feasibility through facility commissioning and clinical readiness.
Technical Support & Application Expertise
Deep clinical physics and engineering support through system operation and beyond.
Customer Engagement & Relationship Management
Sustained engagement with clinical teams, administrators and institutional partners.
Long-term Partnership
Ongoing collaboration across the project lifecycle — supporting expansion, upgrades and emerging capabilities.
Ready to bring the future of particle therapy to India?
Partner with Weembrace and TecAustron today.
